REFERENCES

  1. Birrell SN, Hall RE, Tilley WD. Role of the androgen receptor in human breast cancer. 1998; 3:95-103.
  2. Payne SJ, Bowen RL, Jones JL, Wells CA. Predictive markers in breast cancer the present. Histopathology.2008; 52:82-90.
  3. Ferlay J, Bray F, Pisani P. and Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, version 2.0. IARC Press, Lyon, 2004.
  4. Tewari M, Krishnamurthy A, Shukla HS. Predictive markers of response to neoadjuvant chemotherapy in breast cancer. Surg Oncol. 2008; 7:301-311.
  5. Mohammed HR, Lakatua DJ, Haus E, Yasmineh WJ. Estrogen and progesterone receptors in human breast cancer. Correlation with histological subtype and degree of differentiation in University of Minnesota Cancer Cytopathology -CA: a Cancer Journal for Clinicians.2006; 58:1076-81.
  6. Burstein HJ, Harris JR, Marrow M. Malignant Tumors of the Breast. Devita 8th edition 2008; 43.2: 1606-12.
  7. Bland I K, Beenken WS, Copeland E M.The Breast Schwartz Text Principles of Surgery 9th edition 2008; 15:453-94.
  8. Breasted JH: The Edwin Smith Surgical Papyrus. Chicago: University of Chicago Press,. Classics of MedicineLibrary, vol. III.1930; 405.
  9. Celsus AC: De Medicina, Vol II. Loeb Classical Library Ed, Book V. Cambridge: Harvard University Press, 1935; p. 131.
  10. Beenken SW, et al: History of the therapy of breast cancer, in Bland and Copeland (Eds): The Breast: Comprehensive Management of Benign and Malignant Disorders. Philadelphia: Saunders. 2004; p 5.
  11. Moore C: On the influence of inadequate operations on the theory of cancer. R Med Chir Soc. 1867; 1:244.
  12. Lu Y, Ma H, Malone KE, et al. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J ClinOncol 2011; 29:3358-3365.
  13. Tao MH, Shu XO, Ruan ZX, et al. Association of overweight with breast cancer survival. Am J Epidemiol 2006; 163: 101-107.
  14. Emens LA. Trastuzumab: targeted therapy for the management of HER-2/neu- overexpressing metastatic breast cancer. Am J Ther? 2005; 12:243–253.

 

STATPERSON PUBLISHING GROUP | Aurangabad | Maharashtra |2016 | INDIA
© Copyright 2016 Statperson Publishing Corporation. a division of Statperson Consultancy.
All Rights Reserve